A potential mechanism for AF during ibrutinib is the inhibition of Bruton’s TK protein and tec protein-TK inhibition, which leads to a decrease in phosphoinositide 3‐kinase (PI3k)-Akt activity. This evidence concerns the gene TKT and atrial fibrillation.